Manage Your Liver
Q:

World Hepatitis Day 2016 - Harm reduction is possible!

World Hepatitis Day 2016 - Harm reduction is possible!
A:

World Hepatitis Day 2016 is just around the corner (on July 28), aiming to boost global awareness on hepatitis, this year’s campaign is “Elimination” which can be achieved through universal vaccination, enhanced blood and injection safety, as well as harm reduction and treatment [1].

 

Controlling or eliminating the hepatitis virus has always been regarded as the only way to treat hepatitis. When patients are diagnosed with hepatitis, antiviral treatment is the only option. However, drugs are not able to repair damaged liver cells or normalize liver function. This results in a lack of focus on harm reduction and recovery during the process. In fact, how to effectively reduce injury is essential to preventing the situation from worsening, as only stopping inflammation can reduce the chance of developing other serious liver diseases.

 

Therefore, among the promotional contents of WHD 2016, “harm reduction” should be the primary concern. So what can patients do to reduce injury in everyday life?

 

To reduce injury, patients should first tackle the problem with utmost urgency, which is to stop inflammation in the liver and maintain normal ALT. When inflammation stops, it implies that the liver cells are no longer injured, and damage to the liver can be greatly reduced. [2][3] Therefore, patients should focus on how to stop inflammation early in order to reduce injury.

 

One treatment option that matches this concept is ‘ALT Focused Therapy’. This approach focuses on reducing patients’ injury, overcoming the limitations and shortcomings of the current treatment. ‘ALT Focused Therapy’ can help patients significantly reduce the time with liver injury through rapid recovery of liver cells and opposing inflammation.

 

Find out more about ‘ALT Focused Therapy

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
World Hepatitis Dayharm reduction
Related Questions
A:
Recent research by the University of Edinburgh have gained new insight into how common painkiller paracetamol causes liver damage. The research studied the impact of paracetamol on liver cells in human and mouse tissue.   Toxicity liver damage is currently the leading cause of acute liver failure in the Western world. Long term or excessive use of paracetamol can damage the liver by harming vital structural connections between cells. One of the common result of toxici
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
Hit Questions
A:
Cancer is a leading cause of morbidity and mortality in the United States and results in a high economic burden. A recent research published by The JAMA Network has reveal that cancer mortality declined overall in the United States between 1980 and 2014. And the number of deaths for nearly all forms of cancer has decreased significantly, but not for liver cancer, kidney cancer and non-Hodgkin lymphoma (NHL) cancer.   Deaths due to NHL and kidney cancer remained the sa
A:
Recent research by the University of Edinburgh have gained new insight into how common painkiller paracetamol causes liver damage. The research studied the impact of paracetamol on liver cells in human and mouse tissue.   Toxicity liver damage is currently the leading cause of acute liver failure in the Western world. Long term or excessive use of paracetamol can damage the liver by harming vital structural connections between cells. One of the common result of toxici
A:
Fatty liver is on the rise and it is quickly becoming one of the most worrying disease in developed countries, a condition that most Americans have never heard of and now experts say as many as one in three of us may be at risk. Fatty liver disease is a gradual killer which often shows no symptoms until it develops into a much server problem like: cirrhosis - a condition that could lead to liver cancer or death.   Douglas Denham is medical director at Clinical Trials
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us